Upgrade to SI Premium - Free Trial

Needham Downgrades Sarepta Therapeutics (SRPT) to Hold

July 18, 2025 11:45 AM
Needham analyst Gil Blum downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles